Clinical Trials and Research
Clinical research focuses on the effectiveness and safety of emerging medical advances, such as new drugs and devices not available elsewhere. Unlike laboratory research, clinical research utilizes volunteers and includes mechanisms of human disease, therapeutic interventions, and/or the development of new technologies. Numerous clinical trials also aid in research findings to improve patient care by evaluating emerging therapies, drugs, and tools.
The Maurice R. and Corinne P. Greenberg Division of Cardiology continues its legacy of contributing to cutting-edge clinical research that advanced understanding and treatment of cardiological conditions. With funding from the National Institute of Health and other organizations, our cardiologists are investigating some of the most pressing health questions of our day.
Current areas of research include investigating clinical outcomes; mitral and tricuspid regurgitation; leadless pacemakers; fundamental mechanisms of arrhythmia; EBR ultrasound technology for CRT therapy; mitral, tricuspid, and pulmonary valve devices; and others.
Volunteering for a Clinical Trial
Volunteers are an integral part of the translational research process and clinical studies. Both people with a particular condition and healthy people can play a role in contributing to medical advances. Without volunteers, clinical studies and trials would simply not be possible.
People volunteer for clinical trials for many reasons, including:
- A desire to improve medical care for future generations
- A connection to a certain disease or illness, whether through personal experience or through friends or family
- A personal interest in science
Volunteering for a clinical trial is a personal choice. There is no obligation to do so, and participation is not right for everyone. After enrolling in a study you may choose leave at any time, for any reason. Participating in a clinical trial gives patients access to new therapies and advances in medicine and empowers patients to play a role in improved treatment for future generations. When deciding to participate it is important to consider all aspects of volunteering and the trial itself.
Making an Informed Decision
Informed consent: Before deciding to participate in a study, you will be asked to review an informational document called an informed consent form. This form will provide key facts about the study so you can decide if participating is right for you. You must sign the informed consent form in order to participate in a study, though it is not a contract, you may still choose to leave the study at any time.
Risks and benefits: All medical research involves some level of risk to participants. Risks and benefits vary depending on the particular study. To help you make an informed decision, the study team is required to tell you about all known risks, benefits and available alternative health care options.
Ask questions: If you have questions when deciding to join a research study or at any time throughout, ask a member of the study team. If your questions or concerns are not satisfactorily addressed, you may contact the study's principal investigator, the Weill Cornell Medicine research subject advocate, or the Weill Cornell Medicine Institutional Review Board (IRB).
Protecting rights and safety: A dedicated board of Weill Cornell Medicine medical specialists carefully reviews all potential clinical trials before making them available to you. However, it is important that you understand the potential benefits and risks of participation in any research study.
Clinical Trials Open to Patients
Cardiology patients have the option to participate in one or more clinical trial. Open trials are listed below by condition.
Cardiac Imaging
Cardiac imaging refers to a variety of techniques used to capture detailed views of the heart, enabling precise diagnosis and treatment.
Current Clinical Trials for Cardiac Imaging:
Ventricular Tachycardia
Ventricular tachycardia, also known as V-tach or VT, is a heart rhythm disorder (arrhythmia) caused by abnormal electrical signals in the lower chambers of the heart (ventricles). A healthy heart normally beats about 60 to 100 times a minute when at rest and is defined by signals that originate in the upper chambers of the heart (atria). In ventricular tachycardia abnormal electrical signals in the ventricles cause the heart to beat faster than normal, usually 100 or more beats a minute, out of sync with the upper chambers.
When VT happens, the heart may not be able to pump enough blood to the body and lungs because the chambers are beating so fast or out of sync with each other that they don't have time to fill properly. Ventricular tachycardia may be brief, lasting for only a few seconds, and perhaps not cause any symptoms, or it can last for much longer and cause symptoms such as dizziness, lightheadedness, palpitations or even loss of consciousness.
In some cases, ventricular tachycardia can cause the heart to stop (sudden cardiac arrest), which is a life-threatening medical emergency. This condition usually occurs in people with other heart conditions, such as those who have had a previous heart attack or other structural heart disease (cardiomyopathy).
Current Clinical Trials for Patients with Ventricular Tachycardia:
